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In the era of tissue engineering and
development of novel approaches for
stem cell-driven organ regeneration, it is
important to understand how multipo-
tent stem cells establish distinct pro-
grams of gene expression during their
differentiation into specialized cell
lineages, and why these programs are
altered during pathogenic tissue regen-
eration or expansion (cancer).
It is widely accepted now that line-
age-specific gene expression programs
are governed by signaling/transcrip-
tion factor–dependent and epigenetic
mechanisms. Understanding how these
two key regulatory machineries operate
in concert to coordinate expression of
lineage-specific genes is highly impor-
tant for effective modulation of stem cell
activity/fate and successful translation of
these data into the clinical practice.
Epigenetic mechanisms have an
important role in the control of cellular
functions in living organisms and are
considered to be a driving force of the
phenotypic plasticity and evolutionary
adaptation (Feinberg, 2007). The variabi-
lity in epigenetic status helps to explain
the relationships between an individual
genetic background and effects of the
environment on age-related suscep-
tibility to different diseases (Feinberg,
2013).
Epigenetic regulatory machinery oper-
ates at several levels including modula-
tion of covalent DNA/histone modifica-
tions, as well as through higher-order
chromatin remodeling to establish long-
range topological interactions between
the genes and their enhancer elements
in three-dimensional (3D) nuclear space
(Ho and Crabtree, 2010; Bickmore and
van Steensel, 2013).
The keratinocyte nucleus is a com-
plex and highly compartmentalized
organelle, the 3D organization of which
undergoes major changes during term-
inal differentiation in the epidermis
(Gdula et al., 2013). The program of
epidermal differentiation in mice begins
at about embryonic day 9.5 (E9.5) and
results in the formation of an epidermal
barrier at E18.5 (Koster and Roop, 2007;
Blanpain and Fuchs, 2009). The process
of terminal differentiation in epidermal
cells is accompanied by sequential
changes of gene expression in the
Keratin type I/II loci, followed by the
onset of expression of the epidermal
differentiation complex (EDC) genes
encoding the essential components of
the epidermal barrier (Fuchs and
Horsley, 2011).
The program of epidermal develop-
ment and keratinocyte differentiation is
governed by coordinated involvement
of several transcription factors (p63,
AP-1, Klf4, Arnt, and so on), signaling
pathways (Wnt, Bmp, Hedgehog,
EGF, Notch, FGF, and so on), and
epigenetic regulators (DNA/histone-
modifying enzymes, Polycomb genes,
higher-order and ATP-dependent chro-
matin remodelers, and non-coding
RNAs) that control expression of line-
age-specific genes (reviewed in (Frye
and Benitah, 2012; Botchkarev et al.,
2012; Perdigoto et al., 2014)).
The p63 transcription factor serves as
a master regulator of epidermal deve-
lopment and controls expression of a
large number of genes encoding
adhesion/signaling molecules, transcrip-
tion factors, and cell cycle–associated
and lineage-specific proteins (keratins
and so on; reviewed in (Koster and
Roop, 2007; Vanbokhoven et al.,
2011; Botchkarev and Flores, 2014)).
p63 knockout (KO) mice fail to form
stratified epithelia and to express a
number of epidermis-specific genes
(Mills et al., 1999; Yang et al., 1999).
p63 has several isoforms, including
TAp63 and DNp63, that show distinct
roles in the control of epidermal
stratification, tumor development and
aging (Keyes et al., 2005; Su et al.,
2013).
Epigenetic regulators exhibit both
activating and repressive effects on
chromatin in keratinocytes (KCs): his-
tone demethylase Jmjd3, ATP-depen-
dent chromatin remodeler Brg1, and
genome organizer Satb1 promote term-
inal KC differentiation, while DNA
methyltransferase DNMT1, histone dea-
cetylases HDAC1/2, and Polycomp com-
ponents Bmi1 and Ezh1/2 stimulate
proliferation of progenitor cells via
repression of the genes encoding cell
cycle inhibitors, as well as inhibit pre-
mature activation of terminal differentia-
tion-associated genes (reviewed in (Eckert
et al., 2011; Frye and Benitah, 2012;
Botchkarev et al., 2012; Perdigoto et al.,
2014).
Our recent studies revealed that tran-
scription factor–dependent and epige-
netic regulatory mechanisms in KCs
are highly connected, and p63 has a
hitherto unrecognized role in the higher-
order chromatin remodeling of the EDC
locus via direct control of the genome
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organizer Satb1 and ATP-dependent
chromatin remodeler Brg1 (Fessing
et al., 2011; Mardaryev et al., 2014).
Among different epigenetic regulators,
Satb1 has a unique role in the execution
of lineage-specific gene expression pro-
grams by integrating high-order chroma-
tin organization with regulation of gene
expression (Cai et al., 2006). Satb1 binds
specialized DNA regions and folds
chromatin into loops involving tissue-
specific gene loci (TH2-cytokine and
major histocompatibility complex class
I loci, globin locus, and so on). As well,
it targets chromatin remodelers/trans-
cription factors to gene loci (Kumar
et al., 2007). Satb1 also contributes to
the progression of tumors and promotes
reprogramming of the genome of breast
cancer cells toward metastasis (Kohwi-
Shigematsu et al., 2013).
Satb1 is expressed in basal epidermal
KCs and promotes cell differentiation
via establishing a specific conformation
of the EDC locus, while its ablation in
mice results in the marked elongation of
the EDC central domain associated with
alterations in expression of the EDC
genes and in epidermal morphology
(Fessing et al., 2011).
ATP-dependent chromatin remodeler
Brg1, on the other hand, promotes
developmentally regulated relocation
of the EDC locus from the nuclear
periphery toward nuclear interior into
the compartment enriched by nuclear
speckles, which is associated with
marked increase in expression of the
EDC genes (Mardaryev et al., 2014).
Importantly, conditional ablation of
Brg1 in the epidermis result in failure
to form a functional barrier, thus
partially resembling the phenotype of
p63 KO mice (Indra et al., 2005). These
data suggest that chromatin remodeling
genes represent a novel cohort of p63
targets that mediate its effects on
execution of the lineage-specific gene
expression program in KCs (Botchkarev
et al., 2012; Fessing, 2014).
However, additional efforts are required
to fully understand the complexity of
interactions between distinct signaling
pathway, transcription factors, and
epigenetic regulatory machinery in
the control of epidermal development,
regeneration, and stem cell activity.
Recently, a number of molecules that
are capable of modulating distinct com-
ponents of the epigenetic machinery
have been developed, and some of them
are already approved for treatment of
the distinct neoplastic conditions or
under clinical trials (Heightman, 2011).
Thus, understanding of epigenetic
mechanisms controlling epidermal dif-
ferentiation and skin stem cell activity
and their alterations in different patho-
logical skin conditions will help to
develop a novel cohort of epigenetic
drugs for the treatment of skin disorders.
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